美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=BLA125326"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0078-0669-13 0078-0669 HUMAN PRESCRIPTION DRUG ARZERRA ofatumumab INJECTION, SOLUTION INTRAVENOUS 20160201 N/A BLA BLA125326 Novartis Pharmaceuticals Corporation OFATUMUMAB 20 mg/mL 3 VIAL, SINGLE-USE in 1 CARTON (0078-0669-13) / 5 mL in 1 VIAL, SINGLE-USE (0078-0669-61)
0078-0690-61 0078-0690 HUMAN PRESCRIPTION DRUG ARZERRA ofatumumab INJECTION, SOLUTION INTRAVENOUS 20160201 N/A BLA BLA125326 Novartis Pharmaceuticals Corporation OFATUMUMAB 20 mg/mL 50 mL in 1 VIAL, SINGLE-USE (0078-0690-61)
0078-1007-68 0078-1007 HUMAN PRESCRIPTION DRUG KESIMPTA ofatumumab INJECTION, SOLUTION SUBCUTANEOUS 20200820 N/A BLA BLA125326 Novartis Pharmaceuticals Corporation OFATUMUMAB 20 mg/.4mL 1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS
0078-1007-98 0078-1007 HUMAN PRESCRIPTION DRUG KESIMPTA ofatumumab INJECTION, SOLUTION SUBCUTANEOUS 20200820 N/A BLA BLA125326 Novartis Pharmaceuticals Corporation OFATUMUMAB 20 mg/.4mL 1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase